接受肾脏替代治疗的危重急性肾损伤患者的液体管理:一项国际调查
该国际调查由七个网络于2021年9月至12月发放,共757名来自96个国家的肾脏科与重症医学科医生参与(应答率65%)。多数受访者目标为每日负液体平衡0.5-2升,但安全最大目标差异大;重症医生更常用辅助容量评估,肾脏科医生更常用改善耐受性的协同干预。77%同意比较液体管理策略的试验符合伦理且具临床相关性。
要点
- 多数受访者(91%)在需要液体清除时目标为每日负液体平衡0.5-2升。
- 重症医生较肾脏科医生更常用超声、血流动力学指标和腹腔内压等辅助容量评估。
- 肾脏科医生较重症医生更常用渗透性药物和低温透析液等协同干预。
核心结论
- 调查发现接受肾脏替代治疗的危重患者液体管理实践存在多个方面的差异。
- 多数肾脏科与重症科医生同意若干液体清除策略相关的知识空白应通过未来随机对照试验研究。
研究设计与样本
- 这是一项多国、基于网络的调查,由七个包含肾脏科与重症医学科医生的网络发放。
- 邀请参与危重患者救治的医生完成关于肾脏替代治疗液体管理实践的39题调查。
- 调查发放时间为2021年9月至2021年12月。
主要发现
- 共757名受访者来自96个国家,应答率为65%。
- 多数受访者从事成人医学(89%)并在学术中心工作(69%)。
- 91%的受访者报告当有液体清除指征时目标为每日负液体平衡0.5-2升,但受访者认为的安全最大目标存在重要差异。
- 重症医生较肾脏科医生更可能使用辅助容量状态评估方法(即超声、血流动力学指标和腹腔内压),而肾脏科医生更可能部署旨在改善液体清除耐受性的协同干预(即渗透性药物和低温透析液)。
- 普遍共识认为存在液体蓄积时应优先快速减容,但预防低血压也被报告为竞争性优先事项;77%同意比较液体管理策略的试验符合伦理且具临床相关性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In critically ill patients receiving KRT, high ultrafiltration rates and persistent fluid accumulation are associated with adverse outcomes. The purpose of this international survey was to evaluate current practices and evidence gaps related to fluid removal with KRT in critically ill patients. METHODS: This was a multinational, web-based survey distributed by seven networks comprising nephrologists and intensivists. Physicians involved in the care of critically ill patients were invited to complete a 39-question survey about fluid management practices on KRT. The survey was distributed from September 2021 to December 2021. RESULTS: There were 757 respondents from 96 countries (response rate of 65%). Most respondents practiced adult medicine (89%) and worked in an academic center (69%). The majority (91%) reported aiming for a 0.5- to 2-L negative fluid balance per day when fluid removal is indicated, although there was important variability in what respondents considered a safe maximal target. Intensivists were more likely than nephrologists to use adjunct volume status assessment methods ( i.e. , ultrasound, hemodynamic markers, and intra-abdominal pressure), while nephrologists were more likely to deploy cointerventions aimed at improving tolerance to fluid removal ( i.e. , osmotic agents and low-temperature dialysate). There was a broad consensus that rapid decongestion should be prioritized when fluid accumulation is present, but the prevention of hypotension was also reported as a competing priority. A majority (77%) agreed that performing trials that compare fluid management strategies would be ethical and clinically relevant. CONCLUSIONS: We have identified multiple areas of variability in current practice of fluid management for patients receiving KRT. Most nephrologists and intensivists agreed that several knowledge gaps related to fluid removal strategies should be investigated in future randomized controlled trials.
引用
- Ledoux-Hutchinson L, Wald R, Malbrain MLNG, et al. Fluid Management for Critically Ill Patients with Acute Kidney Injury Receiving Kidney Replacement Therapy: An International Survey. Clin J Am Soc Nephrol. 2023. PMID: 36975194. doi:10.2215/CJN.0000000000000157
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。